Gan

Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)

Thursday, October 14, 2021 - 1:23pm

BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai:603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic.

Key Points: 
  • BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai:603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic.
  • The two studies were conducted separately in subjects with type 1 (n=576) and type 2 diabetes mellitus (n=567).
  • Gan & Lee Pharmaceuticalshasdeveloped the first Chinese domestic biosynthetic human insulin.
  • In the future, Gan & Lee strives to achieve a comprehensive coverage in the field of diabetes diagnosis and treatment.

Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)

Thursday, October 14, 2021 - 1:15pm

BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai:603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic.

Key Points: 
  • BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai:603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin glargine (GL-GLA) to a reference biologic.
  • The two studies were conducted separately in subjects with type 1 (n=576) and type 2 diabetes mellitus (n=567).
  • Gan & Lee Pharmaceuticalshasdeveloped the first Chinese domestic biosynthetic human insulin.
  • In the future, Gan & Lee strives to achieve a comprehensive coverage in the field of diabetes diagnosis and treatment.

A&G Wins Third Award for its Role in Tuesday Morning's Chapter 11 Restructuring and Second for GNC's Successful Turnaround

Monday, September 27, 2021 - 1:41pm

(Those prior awards came from the Global M&A Network and the Turnaround Management Association.)

Key Points: 
  • (Those prior awards came from the Global M&A Network and the Turnaround Management Association.)
  • The M&A Advisor's 15th-Annual Turnaround Awards recognize those deals "that reached the pinnacle of the distressed investing, bankruptcy, and restructuring industry over the past year," according to the New York-based publisher.
  • On GNC's turnaround, A&G teamed with GNC executives and the company's financial advisors to adjust strategy and goals post-bankruptcy filing.
  • The GNC restructuring won in the category of "Cross-Border Restructuring of the Year" ($500MM to $1B).

A&G Wins Another Award for its Work on the Chapter 11 Restructuring of Off-Price Retailer Tuesday Morning

Tuesday, September 21, 2021 - 1:38pm

Melville-based A&Gan advisory firm specializing in lease restructuring , real estate sales and auctions nationwidewas recognized along with other professional, advisory and banking firms that assisted Tuesday Morning on the restructuring.

Key Points: 
  • Melville-based A&Gan advisory firm specializing in lease restructuring , real estate sales and auctions nationwidewas recognized along with other professional, advisory and banking firms that assisted Tuesday Morning on the restructuring.
  • Tuesday Morning, which filed for bankruptcy protection in May 2020, announced this past January that it had successfully completed its financial and operational reorganization and emerged from Chapter 11.
  • The Turnaround/Transaction of the Year Awards are chosen based on a rigorous peer-review process by the volunteer TMA Awards Committee.
  • Chicago-based TMA will honor this year's 10 award recipients at the TMA Annual Conference October 26-29 in Nashville and online.

GAN Schedules 2021 Second Quarter Financial Results Announcement and Conference Call for August 16, 2021

Tuesday, August 3, 2021 - 12:30pm

GAN Limited (the Company or GAN) (NASDAQ: GAN), a leading full-service internet gambling software-as-a-service provider to the U.S. land-based casino industry today announced that it will release financial results for the second quarter ended June 30, 2021 after market close on Monday, August 16, 2021 via news release.

Key Points: 
  • GAN Limited (the Company or GAN) (NASDAQ: GAN), a leading full-service internet gambling software-as-a-service provider to the U.S. land-based casino industry today announced that it will release financial results for the second quarter ended June 30, 2021 after market close on Monday, August 16, 2021 via news release.
  • The news release will be available at www.GAN.com .
  • Company management will host a conference call and webcast to discuss these financial results, the Company's business and outlook at 4:30 PM EST that same day.
  • A replay of the webcast will be archived shortly after the call and can be accessed for approximately 90 days on the Company's website.

Navitas to Participate in CJS Securities "New Ideas" Summer Conference

Tuesday, July 6, 2021 - 12:00pm

DUBLIN, July 6, 2021 /PRNewswire/ -- Navitas Semiconductor, the industry leader in gallium nitride (GaN) power ICs, announced participation in the 21st Annual CJS Securities "New Ideas" (Virtual) Summer Conference, on July 13th, 2021.

Key Points: 
  • DUBLIN, July 6, 2021 /PRNewswire/ -- Navitas Semiconductor, the industry leader in gallium nitride (GaN) power ICs, announced participation in the 21st Annual CJS Securities "New Ideas" (Virtual) Summer Conference, on July 13th, 2021.
  • To attend the Navitas 'fire-side chat' on July 13th at 3.45pm EDT, or to arrange a 1-on-1 meeting with the Navitas team, please contact CJS at info@cjs-securities.com .
  • CJS Securities , Inc. is a FINRA-registered broker-dealer focused on publishing equity research for institutional investors.
  • Live Oak II and Navitas anticipate that subsequent events and developments will cause Live Oak II's and Navitas' assessments to change.

Transphorm Appoints Ms. Kelly Smales to Board of Directors

Wednesday, June 30, 2021 - 9:05pm

Transphorm, Inc. (OTCQX: TGAN)a pioneer in and global supplier of high reliability, high performance gallium nitride (GaN) power conversion products, today announced the appointment of Kelly Smales to the companys Board of Directors effective July 1, 2021.

Key Points: 
  • Transphorm, Inc. (OTCQX: TGAN)a pioneer in and global supplier of high reliability, high performance gallium nitride (GaN) power conversion products, today announced the appointment of Kelly Smales to the companys Board of Directors effective July 1, 2021.
  • We are pleased to welcome Kelly as a new independent director and add her proven financial acumen within the semiconductor industry to Transphorms Board, stated Mario Rivas, Chief Executive Officer, of Transphorm.
  • Concurrent with Ms. Smales appointment, David Kerko resigned from Transphorms Board of Directors effective June 30, 2021.
  • We are grateful to David for his dedication to Transphorm and wish him the very best in his future endeavors.

Gallium Nitride (GaN) Semiconductor Devices Market with COVID-19 Impact Analysis by Device Type, Wafer Size, Application, Vertical and Geography - Global Forecast to 2026 - ResearchAndMarkets.com

Tuesday, June 22, 2021 - 12:26pm

The "Global Gallium Nitride (GaN) Semiconductor Devices Market with COVID-19 Impact Analysis by Device Type (RF, Power, Opto), Wafer Size, Application, Vertical (Consumer & Enterprises, Automotive, Telecommunications), and Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gallium Nitride (GaN) Semiconductor Devices Market with COVID-19 Impact Analysis by Device Type (RF, Power, Opto), Wafer Size, Application, Vertical (Consumer & Enterprises, Automotive, Telecommunications), and Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The opto-semiconductors segment for the GaN semiconductor device market is projected to hold the largest market share in 2026, by device type.
  • The renewables segment for the GaN semiconductor device market is estimated to register the highest CAGR growth during the forecast period, by vertical.
  • APAC is projected to register the largest market size of the GaN semiconductor device market by 2026.

GAN Appoints Susan Bracey to the Company’s Board of Directors

Friday, June 11, 2021 - 12:30pm

GAN Limited (the Company or GAN) (NASDAQ: GAN), a leading full-service internet gaming software-as-a-service provider to the real money internet gaming, online sports betting, and simulated gaming industries, today announced that it has appointed Susan Bracey to its Board of Directors (the Board), effectively immediately.

Key Points: 
  • GAN Limited (the Company or GAN) (NASDAQ: GAN), a leading full-service internet gaming software-as-a-service provider to the real money internet gaming, online sports betting, and simulated gaming industries, today announced that it has appointed Susan Bracey to its Board of Directors (the Board), effectively immediately.
  • Dermot Smurfit, Director and CEO of GAN, commented:
    We are excited to have Susan join GANs Board and know she will provide invaluable guidance as we execute our growth strategy.
  • I am pleased to be joining the Board of Directors of an industry-leading company like GAN.
  • From 2000 to 2008, Ms. Bracey was an executive at Ticketmaster Entertainment, where she served as EVP and Chief Financial Officer.

GaN Systems Paves the Way for Power Electronics Innovation at APEC 2021

Wednesday, June 9, 2021 - 2:07pm

Ottawa, Ontario--(Newsfile Corp. - June 9, 2021) - GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced it will showcase its most recent GaN-based solutions at the Applied Power Electronics Conference (APEC) 2021, taking place from June 14-17, 2021.

Key Points: 
  • Ottawa, Ontario--(Newsfile Corp. - June 9, 2021) - GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced it will showcase its most recent GaN-based solutions at the Applied Power Electronics Conference (APEC) 2021, taking place from June 14-17, 2021.
  • GaN Systems is the global leader in GaN power semiconductors with the most extensive transistors portfolio that uniquely addresses the needs of todays most demanding industries, including consumer electronics, data center servers, and power supplies, renewable energy systems, industrial motors, and automotive electronics.
  • As an industry-leading innovator, GaN Systems makes possible the design of smaller, lower cost, more efficient power systems.
  • By changing the transistor performance rules, GaN Systems enables power conversion companies to revolutionize their industries and transform the world.